The scleroderma therapeutics market is a segment of the pharmaceutical and healthcare industry dedicated to the research, development, manufacturing, and distribution of treatments and therapies for scleroderma, a rare and chronic autoimmune disease. Scleroderma, also known as systemic sclerosis, is characterized by the abnormal growth of connective tissue in the skin and various internal organs. The […]
Scleroderma, a complex and rare autoimmune disease, affects millions of people globally, leading to varying degrees of skin thickening, internal organ involvement, and significant impact on patients’ lives. At [Your Company/Institution Name], we understand the urgency and gravity of finding effective solutions for this debilitating condition. Hence, we have focused our resources and expertise […]